Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 12/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 11/20 | 1.00 |
| ▸ | NPC1 | O15118 | 10/20 | 1.00 |
| ▸ | RAB9A | P51151 | 10/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | GFER | P55789 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 4/20 | 0.72 |
| ▸ | USP2 | O75604 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | GLA | P06280 | 4/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.69 |
| ▸ | RECQL | P46063 | 2/20 | 0.69 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL31379729 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| Methane SCHEMBL28366167 | 0.98 | ALDH1A1 (0.96) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL2248110 | 0.91 | SMN1; SMN2 (0.82) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL29386825 | 0.90 | NPC1 (0.88) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL2178266 | 0.90 | NPC1 (0.88) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL24295036 | 0.88 | NPC1 (0.84) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL22499602 | 0.86 | NPC1 (0.81) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL2252555 | 0.85 | NPC1 (0.92) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL6506352 | 0.84 | HPSE (0.87) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A | |
| SCHEMBL105095 | 0.84 | NPC1 (1.00) | ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025013869-A1 | FLUORINE-CONTAINING POLYMER HAVING NITROGEN-CONTAINING AROMATIC RING, PRODUCTION METHOD THEREFOR, AND COMPOSITION THEREOF | ダイキン工業株式会社 | 2025-01-16 | — | — | WO | claimed |
| CN-116836382-A | Halogen-free antibacterial polyamide and preparation method thereof | 四川轻化工大学 | 2023-10-03 | — | — | CN | claimed |
| CN-111808306-B | Polyimide film with low thermal expansion coefficient and preparation method thereof | 浙江中科玖源新材料有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-111808306-A | Polyimide film with low thermal expansion coefficient and preparation method thereof | 浙江中科玖源新材料有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-105705688-B | The fiber of the mixture of copolymer comprising poly- (mpd-i) and made of 5 (6) amino 2 (p-aminophenyl) benzimidazoles | 纳幕尔杜邦公司 | 2018-04-03 | — | — | CN | claimed |
| CN-105705689-B | The sheet material and fibrid of the mixture for the copolymer being made comprising poly- (mpd-i) and by 5 (6) amino 2 (p-aminophenyl) benzimidazoles | 纳幕尔杜邦公司 | 2017-11-07 | — | — | CN | claimed |
| CN-104040052-B | The method for preparing the aramid copolymer yarn with low remaining sulphur | 纳幕尔杜邦公司 | 2017-06-20 | — | — | CN | claimed |
| CN-103314142-B | The preparation of copolymer fibre and drying | 纳幕尔杜邦公司 | 2017-03-01 | — | — | CN | claimed |
| EP-2889027-A2 | Oral preparation, injection preparation, external skin preparation and cosmetic method for preventing or improving wrinkles | Shiseido Co., Ltd. (JP) | 2015-07-01 | — | — | EP | claimed |
| EP-2295028-A1 | PREPARATION FOR PREVENTING OR AMELIORATING WRINKLES, TO BE TAKEN ORALLY, THROUGH INJECTION, OR THROUGH EXTERNAL APPLICATION TO SKIN, AND COSMETIC METHOD | Shiseido Company, Ltd. (JP) | 2011-03-16 | — | — | EP | claimed |
| US-20110020477-A1 | ORAL PREPARATION, INJECTION PREPARATION, EXTERNAL SKIN PREPARATION AND COSMETIC METHOD FOR PREVENTING OR IMPROVING WRINKLES | SHISEIDO COMPANY, LTD. | 2011-01-27 | — | — | US | claimed |
| EP-1635821-B1 | 4-BROMO-5-(2-CHLORO-BENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXYLIC ACID (PHENYL)AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2009-07-08 | — | — | EP | claimed |
| US-20070123531-A1 | 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases | ELAN PHARMACEUTICALS, INC. | 2007-05-31 | — | — | US | claimed |
| US-20050032868-A1 | Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | ELAN PHARMACEUTICALS, INC. | 2005-02-10 | — | — | US | claimed |
| EP-0226016-A1 | Process for inhibiting hydrogen-induced corrosion of metallic materials | BAYER AG (DE) | 1987-06-24 | — | — | EP | claimed |
| US-4119478-A | COLORLESS COMPOUND CONTAINING ONE OR MORE BASIC NITROGEN ATOMS ATTACHED TO CARBON IN PYRIDINE OR BENZIMIDAZOLE RING AND HAVING ONE OR MORE UREA OR URETHANE GROUPS | CIBA-GEIGY CORPORATION (US) | 1978-10-10 | — | — | US | claimed |
| JP-11071448-A | — | — | None | — | — | JP | disclosed |
| CN-122036621-A | Fluorine substituted benzimidazolyl aniline compound and synthetic method and application thereof | 中茂绿能科技(西安)有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-0057245-A2 | Cationic triazine dyestuffs, their preparation and their use | BAYER AG (DE) | 1982-08-11 | — | — | EP | disclosed |
| US-4119478-A | COLORLESS COMPOUND CONTAINING ONE OR MORE BASIC NITROGEN ATOMS ATTACHED TO CARBON IN PYRIDINE OR BENZIMIDAZOLE RING AND HAVING ONE OR MORE UREA OR URETHANE GROUPS | CIBA-GEIGY CORPORATION (US) | 1978-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123531-A1 | 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases | BDKRB1, BDKRB2, LTB4R | ALDH1A1 1890/4885KDM4E 3612/4885SMN1; SMN2 3517/4885 |
| US-20050032868-A1 | Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists | BDKRB1, BDKRB2, BRS3 | ALDH1A1 3108/4885KDM4E 4512/4885SMN1; SMN2 3416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.